Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Current Assets (2016 - 2025)

Avanos Medical's Current Assets history spans 11 years, with the latest figure at $472.6 million for Q3 2024.

  • For Q3 2024, Current Assets fell 9.91% year-over-year to $472.6 million; the TTM value through Sep 2024 reached $472.6 million, down 9.91%, while the annual FY2023 figure was $487.0 million, 21.97% down from the prior year.
  • Current Assets for Q3 2024 was $472.6 million at Avanos Medical, roughly flat from $474.1 million in the prior quarter.
  • Across five years, Current Assets topped out at $624.1 million in Q4 2022 and bottomed at $405.0 million in Q3 2021.
  • The 5-year median for Current Assets is $470.0 million (2022), against an average of $482.0 million.
  • The largest annual shift saw Current Assets fell 28.65% in 2021 before it surged 45.95% in 2022.
  • A 5-year view of Current Assets shows it stood at $467.2 million in 2020, then fell by 8.48% to $427.6 million in 2021, then soared by 45.95% to $624.1 million in 2022, then decreased by 21.97% to $487.0 million in 2023, then fell by 2.96% to $472.6 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Current Assets are $472.6 million (Q3 2024), $474.1 million (Q2 2024), and $467.8 million (Q1 2024).